Indirubine-3-Monoxime Inhibits PDGF-Mediated Vascular Smooth Muscle Cell Migration
Department of Pharmacognosy, University of Vienna, Althanstr. 14, 1090, Vienna, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 244; https://doi.org/10.3797/scipharm.oephg.21.PO-45
Submission received: 16 April 2009
/
Accepted: 16 April 2009
/
Published: 16 April 2009
Abstract
During the pathology of atherosclerosis and restenosis, hyperproliferation and migration of vascular smooth muscle cells (VSMC) contribute to lumen loss of the vessel and neointima formation [1]. Drugs interfering with both, proliferation and migration of VSMC are therefore promising candidates for the treatment of vasculoproliferative diseases.
Share and Cite
MDPI and ACS Style
SROKA, I.; HEISS, E.H.; CZALOUN, C.; DIRSCH, V.M. Indirubine-3-Monoxime Inhibits PDGF-Mediated Vascular Smooth Muscle Cell Migration. Sci. Pharm. 2009, 77, 244. https://doi.org/10.3797/scipharm.oephg.21.PO-45
AMA Style
SROKA I, HEISS EH, CZALOUN C, DIRSCH VM. Indirubine-3-Monoxime Inhibits PDGF-Mediated Vascular Smooth Muscle Cell Migration. Scientia Pharmaceutica. 2009; 77(Posters (PO)):244. https://doi.org/10.3797/scipharm.oephg.21.PO-45
Chicago/Turabian StyleSROKA, I., E. H. HEISS, C. CZALOUN, and V. M. DIRSCH. 2009. "Indirubine-3-Monoxime Inhibits PDGF-Mediated Vascular Smooth Muscle Cell Migration" Scientia Pharmaceutica 77, Posters (PO): 244. https://doi.org/10.3797/scipharm.oephg.21.PO-45
